NBIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $87,289,373.58

Neurocrine Biosciences Insider Trading History Chart

Neurocrine Biosciences Share Price & Price History

^$166.80

+0.30 (1.20%)

As of 07/31/2026 04:00 PM ET

Days: 30 | 90 | 365

Neurocrine Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/28/2026	Leslie V Norwalk	Director	Sell	1,250	$182.01	$227,512.50	1,588
7/10/2026	Ingrid Delaet	Insider	Sell	4,367	$181.02	$790,514.34	16,225
7/9/2026	Darin Lippoldt	Insider	Sell	10,000	$179.60	$1,796,000.00	54,729
7/9/2026	Ingrid Delaet	Insider	Sell	8,433	$178.72	$1,507,145.76	16,225
7/8/2026	Ingrid Delaet	Insider	Sell	2,737	$178.54	$488,663.98	16,225
7/7/2026	Ingrid Delaet	Insider	Sell	3,401	$178.57	$607,316.57	16,225
6/29/2026	Darin Lippoldt	Insider	Sell	9,800	$170.16	$1,667,568.00	54,729
6/26/2026	Darin Lippoldt	Insider	Sell	200	$169.56	$33,912.00	54,729
6/5/2026	Stephen A. Sherwin	Director	Sell	25,000	$165.32	$4,133,000.00	15,860
6/4/2026	Leslie V Norwalk	Director	Sell	1,250	$168.06	$210,075.00	2,838
6/2/2026	Julie Cooke	Insider	Sell	36,937	$156.22	$5,770,298.14	22,374
6/1/2026	Jude Onyia	Insider	Sell	11,000	$160.25	$1,762,750.00	25,846
5/29/2026	Ingrid Delaet	Insider	Sell	2,261	$156.71	$354,321.31	16,225
5/27/2026	Jude Onyia	Insider	Sell	11,000	$155.53	$1,710,830.00	25,846
5/26/2026	David W. Boyer	Insider	Sell	3,888	$156.64	$609,016.32	7,799
5/19/2026	Kevin Charles Gorman	Director	Sell	245,088	$154.33	$37,824,431.04	511,293
5/15/2026	Richard F. Pops	Director	Sell	15,000	$157.65	$2,364,750.00	34,480
5/12/2026	Leslie V Norwalk	Director	Sell	3,810	$155.01	$590,588.10	2,429
1/16/2026	Kyle Gano	CEO	Sell	36,400	$132.70	$4,830,280.00	140,407
12/16/2025	Leslie V Norwalk	Director	Sell	1,190	$155.09	$184,557.10	6,239
12/15/2025	Leslie V Norwalk	Director	Sell	5,000	$152.23	$761,150.00	7,429
12/8/2025	Darin Lippoldt	Insider	Sell	4,376	$159.65	$698,628.40	43,405
11/25/2025	George J Morrow	Director	Sell	15,000	$143.37	$2,150,550.00	7,068
11/5/2025	William H. Rastetter	Director	Sell	18,000	$151.82	$2,732,760.00	40,360
11/4/2025	Kyle Gano	CEO	Sell	300	$141.97	$42,591.00	140,407
8/7/2025	Kevin Charles Gorman	Director	Sell	106,322	$126.41	$13,440,164.02	514,596
7/10/2025	Ingrid Delaet	Insider	Sell	457	$135.00	$61,695.00	4,730
7/9/2025	Jude Onyia	Insider	Sell	59,819	$130.46	$7,803,986.74	18,289
7/2/2025	Jude Onyia	Insider	Sell	20,362	$130.13	$2,649,707.06	18,289
5/27/2025	Kevin Charles Gorman	Director	Sell	9,613	$120.38	$1,157,212.94	514,596
5/5/2025	William H. Rastetter	Director	Sell	30,000	$110.20	$3,306,000.00	37,491
2/13/2025	Julie Cooke	Insider	Sell	1,551	$116.78	$181,125.78	19,544
2/13/2025	Kevin Charles Gorman	Director	Sell	5,844	$116.69	$681,936.36	521,618
2/13/2025	Matt Abernethy	CFO	Sell	2,558	$116.86	$298,927.88	34,775
2/10/2025	Julie Cooke	Insider	Sell	700	$118.28	$82,796.00	18,831
2/10/2025	Kevin Charles Gorman	Director	Sell	2,274	$118.37	$269,173.38	519,074
2/10/2025	Kyle Gano	CEO	Sell	980	$118.39	$116,022.20	137,658
2/3/2025	Ingrid Delaet	Insider	Sell	623	$149.29	$93,007.67	3,442
1/31/2025	Julie Cooke	Insider	Sell	1,740	$152.89	$266,028.60	18,202
1/31/2025	Kevin Charles Gorman	Director	Sell	2,707	$152.92	$413,954.44	517,030
1/31/2025	Kyle Gano	CEO	Sell	1,541	$152.87	$235,572.67	136,778
1/31/2025	Matt Abernethy	CFO	Sell	1,283	$152.87	$196,132.21	32,681
1/27/2025	Kevin Charles Gorman	Director	Sell	146,105	$149.46	$21,836,853.30	514,596
1/15/2025	Kyle Gano	CEO	Sell	65,000	$141.50	$9,197,500.00	135,392
12/31/2024	Ingrid Delaet	Insider	Sell	272	$138.10	$37,563.20	2,507
12/17/2024	Ingrid Delaet	Insider	Sell	1,091	$135.00	$147,285.00	2,507
11/29/2024	Jude Onyia	Insider	Sell	2,331	$126.29	$294,381.99	15,449
8/15/2024	William H. Rastetter	Director	Sell	14,250	$146.69	$2,090,332.50	37,491
8/13/2024	Gary A. Lyons	Director	Sell	11,570	$150.43	$1,740,475.10	119,047
8/13/2024	Ingrid Delaet	Insider	Sell	7,143	$150.10	$1,072,164.30	2,507
8/13/2024	Matt Abernethy	CFO	Sell	14,100	$150.38	$2,120,358.00	31,528
8/6/2024	Ingrid Delaet	Insider	Sell	273	$147.70	$40,322.10	6,607
8/1/2024	Julie Cooke	Insider	Sell	12,632	$153.26	$1,935,980.32	18,202
7/16/2024	Gary A. Lyons	Director	Sell	930	$150.03	$139,527.90	119,047
7/16/2024	Julie Cooke	Insider	Sell	900	$150.04	$135,036.00	18,202
7/1/2024	Julie Cooke	Insider	Sell	10,000	$140.19	$1,401,900.00	18,202
5/29/2024	Stephen A. Sherwin	Director	Sell	40,000	$133.46	$5,338,400.00	26,504
5/17/2024	Shalini Sharp	Director	Sell	1,106	$141.90	$156,941.40	994
5/15/2024	Matt Abernethy	CFO	Sell	15,000	$140.24	$2,103,600.00	31,528
5/14/2024	Gary A. Lyons	Director	Sell	12,500	$135.63	$1,695,375.00	116,947
5/6/2024	Ingrid Delaet	Insider	Sell	273	$140.55	$38,370.15	7,507
4/15/2024	Eric Benevich	Insider	Sell	19,818	$133.36	$2,642,928.48	40,778
3/21/2024	Ingrid Delaet	Insider	Sell	5,000	$145.06	$725,300.00	7,507
3/14/2024	Eric Benevich	Insider	Sell	75,000	$139.38	$10,453,500.00	40,778
3/14/2024	George J. Morrow	Director	Sell	40,000	$139.42	$5,576,800.00
3/11/2024	Ingrid Delaet	Insider	Sell	200	$140.00	$28,000.00	7,507
3/11/2024	Richard F. Pops	Director	Sell	100	$140.00	$14,000.00	29,512
3/8/2024	Ingrid Delaet	Insider	Sell	1,800	$140.03	$252,054.00	7,507
3/8/2024	Richard F. Pops	Director	Sell	1,700	$140.05	$238,085.00	29,512
2/29/2024	Ingrid Delaet	Insider	Sell	273	$135.51	$36,994.23	7,507
2/27/2024	Leslie V. Norwalk	Director	Sell	8,000	$135.67	$1,085,360.00
2/20/2024	Richard F. Pops	Director	Sell	15,000	$132.47	$1,987,050.00	29,512
2/13/2024	Eiry Roberts	Insider	Sell	1,114	$132.96	$148,117.44	23,716
2/13/2024	Kevin Charles Gorman	CEO	Sell	2,832	$133.02	$376,712.64	514,596
2/13/2024	Matt Abernethy	CFO	Sell	1,352	$132.85	$179,613.20	31,528
2/8/2024	David W. Boyer	Insider	Sell	1,328	$135.41	$179,824.48	4,895
2/8/2024	Kevin Charles Gorman	CEO	Sell	2,274	$134.15	$305,057.10	506,962
2/8/2024	Matt Abernethy	CFO	Sell	980	$134.21	$131,525.80	30,314
2/6/2024	David W. Boyer	Insider	Sell	456	$141.96	$64,733.76	4,894
2/6/2024	Kevin Charles Gorman	CEO	Sell	3,040	$142.18	$432,227.20	504,919
2/6/2024	Matt Abernethy	CFO	Sell	1,280	$142.19	$182,003.20	29,434
1/31/2024	Eiry Roberts	Insider	Sell	1,457	$140.79	$205,131.03	20,832
1/31/2024	Kevin Charles Gorman	CEO	Sell	2,707	$140.69	$380,847.83	502,188
1/31/2024	Matt Abernethy	CFO	Sell	1,283	$140.72	$180,543.76	28,284
1/22/2024	Darin Lippoldt	Insider	Sell	10,000	$139.86	$1,398,600.00	35,882
1/8/2024	Kevin Charles Gorman	CEO	Sell	105,835	$132.44	$14,016,787.40	499,754
1/2/2024	Kyle Gano	Insider	Sell	75,000	$131.47	$9,860,250.00	130,250
1/2/2024	William H. Rastetter	Director	Sell	11,044	$131.47	$1,451,954.68	51,741
12/22/2023	Eiry Roberts	Insider	Sell	10,000	$126.74	$1,267,400.00	19,521
12/12/2023	Eiry Roberts	Insider	Sell	13,925	$120.30	$1,675,177.50	29,521
12/8/2023	Eiry Roberts	Insider	Sell	300	$120.10	$36,030.00	29,521
12/6/2023	Darin Lippoldt	Insider	Sell	20,830	$119.86	$2,496,683.80	35,882
12/1/2023	Gary A. Lyons	Director	Sell	5,000	$116.77	$583,850.00	203,697
11/29/2023	Jude Onyia	Insider	Sell	2,331	$113.57	$264,731.67	11,732
11/27/2023	Darin Lippoldt	Insider	Sell	10,919	$112.27	$1,225,876.13	35,882
10/2/2023	David W. Boyer	Insider	Sell	1,437	$112.68	$161,921.16	4,894
9/12/2023	Gary A. Lyons	Director	Sell	5,000	$115.02	$575,100.00	203,697
9/1/2023	Gary A. Lyons	Director	Sell	5,000	$110.06	$550,300.00	203,697
9/1/2023	Julie Cooke	Insider	Sell	824	$110.93	$91,406.32	17,263
8/30/2023	David W. Boyer	Insider	Sell	2,733	$107.60	$294,070.80	3,460
8/28/2023	Ingrid Delaet	Insider	Sell	1,431	$107.52	$153,861.12	5,931
8/21/2023	Jude Onyia	Insider	Sell	3,198	$107.37	$343,369.26	9,638
8/21/2023	Kevin Charles Gorman	CEO	Sell	9,328	$107.40	$1,001,827.20	499,754
8/21/2023	Matt Abernethy	CFO	Sell	2,132	$107.39	$228,955.48	27,131

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

92.59% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neurocrine Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/10/2026	Generali Investments Management Co LLC	10,644	$1.79M	0.4%	+19.8%	0.011%
7/10/2026	Handelsbanken Fonder AB	205,871	$34.70M	0.1%	+9.6%	0.205%
7/10/2026	Fulton Bank N.A.	4,895	$0.83M	0.0%	+5.2%	0.005%
7/9/2026	Valeo Financial Advisors LLC	1,679	$0.28M	0.0%	N/A	0.002%
7/8/2026	Trust Point Inc.	1,455	$0.25M	0.0%	N/A	0.001%
7/8/2026	PKO BP BANKOWY Universal Pension Society JSC	170,802	$28.79M	8.2%	+23.1%	0.170%
7/8/2026	PensionDanmark Pensionsforsikringsaktieselskab	38,791	$6.54M	0.1%	+11.9%	0.039%
7/8/2026	Assenagon Asset Management S.A.	222,606	$37.52M	0.0%	+143.3%	0.221%
7/8/2026	Red Spruce Capital LLC	16,693	$2.81M	1.0%	-3.0%	0.017%
7/7/2026	BDF Gestion	11,858	$2M	0.3%	N/A	0.012%
7/7/2026	GAMMA Investing LLC	3,714	$0.63M	0.0%	+30.5%	0.004%
7/7/2026	Avior Wealth Management LLC	2,979	$0.50M	0.0%	N/A	0.003%
7/7/2026	Harbor Investment Advisory LLC	660	$0.11M	0.0%	N/A	0.001%
7/7/2026	City Center Advisors LLC	2,245	$0.38M	0.3%	N/A	0.002%
7/6/2026	Private Client Services LLC	3,156	$0.53M	0.1%	-74.7%	0.003%
7/2/2026	Versant Capital Management Inc	737	$0.12M	0.0%	+30.9%	0.001%
6/24/2026	Basecamp Wealth Advisors LLC	239	$31K	0.0%	+582.9%	0.000%
6/18/2026	Pacer Advisors Inc.	169,230	$22.29M	0.0%	+471.3%	0.168%
6/15/2026	Carmignac Gestion	186,000	$24.50M	0.4%	+192.5%	0.185%
6/12/2026	Defilade Capital Management L.P.	209,932	$27.66M	3.9%	N/A	0.209%
6/3/2026	Parallel Advisors LLC	1,776	$0.23M	0.0%	+12.3%	0.002%
6/3/2026	NewEdge Advisors LLC	13,066	$1.72M	0.0%	+0.5%	0.013%
6/1/2026	Caerus Investment Advisors LLC	2,526	$0.33M	0.1%	-51.9%	0.003%
5/29/2026	Perceptive Advisors LLC	65,050	$8.57M	0.2%	-80.4%	0.065%
5/26/2026	Glenmede Trust Co. NA	78,577	$10.35M	0.1%	-3.8%	0.078%
5/22/2026	Segall Bryant & Hamill LLC	56,934	$7.50M	0.1%	+0.8%	0.057%
5/21/2026	Essential Partners LLC	5,469	$0.72M	0.2%	-10.4%	0.005%
5/20/2026	Arete Wealth Advisors LLC	23,053	$3.04M	0.2%	N/A	0.023%
5/19/2026	Winnow Wealth LLC	5,950	$0.78M	0.6%	-5.0%	0.006%
5/19/2026	Bank of America Corp DE	583,827	$76.91M	0.0%	+10.6%	0.581%
5/19/2026	Edgestream Partners L.P.	50,587	$6.66M	0.2%	+134.1%	0.050%
5/19/2026	Janus Henderson Group PLC	466,977	$61.52M	0.0%	+1.7%	0.464%
5/19/2026	Oddo BHF Asset Management Sas	8,039	$1.06M	0.0%	+5.5%	0.008%
5/19/2026	Bull Harbor Capital LLC	9,213	$1.21M	0.3%	N/A	0.009%
5/19/2026	Arete Wealth Advisors LLC	23,053	$3.04M	0.2%	N/A	0.023%
5/18/2026	ADAR1 Capital Management LLC	2,500	$0.33M	0.0%	N/A	0.002%
5/18/2026	Amundi	203,637	$26.83M	0.0%	+22.4%	0.203%
5/18/2026	EverSource Wealth Advisors LLC	4,557	$0.60M	0.0%	+4.6%	0.005%
5/18/2026	Talon Private Wealth LLC	4,789	$0.63M	0.1%	N/A	0.005%
5/18/2026	California State Teachers Retirement System	132,643	$17.47M	0.0%	-1.1%	0.132%
5/18/2026	Royal Bank of Canada	332,300	$43.78M	0.0%	+6.8%	0.330%
5/18/2026	Rock Springs Capital Management LP	150,450	$19.82M	1.2%	+19.9%	0.150%
5/18/2026	Empowered Funds LLC	83,971	$11.06M	0.1%	+1,823.3%	0.084%
5/16/2026	The Manufacturers Life Insurance Company	68,112	$8.97M	0.0%	-25.7%	0.068%
5/16/2026	Quantinno Capital Management LP	69,499	$9.16M	0.0%	+157.5%	0.069%
5/16/2026	Lazard Asset Management LLC	124,479	$16.40M	0.0%	+91.7%	0.124%
5/15/2026	OMERS ADMINISTRATION Corp	4,615	$0.61M	0.0%	+30.1%	0.005%
5/15/2026	Rice Hall James & Associates LLC	99,990	$13.17M	0.7%	+2.0%	0.099%
5/15/2026	Waverly Advisors LLC	5,166	$0.68M	0.0%	+15.5%	0.005%
5/15/2026	Entropy Technologies LP	23,677	$3.12M	0.1%	+5.1%	0.024%
5/14/2026	Healthcare of Ontario Pension Plan Trust Fund	23,400	$3.08M	0.0%	N/A	0.023%
5/14/2026	Renaissance Technologies LLC	2,418,897	$318.67M	0.5%	+8.0%	2.406%
5/14/2026	Public Employees Retirement System of Ohio	30,989	$4.08M	0.0%	-2.8%	0.031%
5/14/2026	Bank of Nova Scotia	7,099	$0.94M	0.0%	-5.7%	0.007%
5/14/2026	Sei Investments Co.	235,251	$30.99M	0.0%	+31.1%	0.234%
5/14/2026	Lido Advisors LLC	3,025	$0.40M	0.0%	+64.8%	0.003%
5/14/2026	Globeflex Capital L P	28,173	$3.71M	0.6%	-4.5%	0.028%
5/14/2026	State of Wyoming	1,521	$0.20M	0.0%	-45.6%	0.002%
5/13/2026	Cetera Investment Advisers	20,245	$2.67M	0.0%	+50.1%	0.020%
5/13/2026	Aureus Asset Management LLC	9,511	$1.25M	0.1%	N/A	0.009%
5/13/2026	CI Investments Inc.	2,587	$0.34M	0.0%	-5.4%	0.003%
5/13/2026	First Trust Advisors LP	959,217	$126.37M	0.1%	+97.0%	0.954%
5/12/2026	Westpac Banking Corp	1,615	$0.21M	0.0%	+6.0%	0.002%
5/12/2026	ABN Amro Investment Solutions	3,040	$0.40M	0.0%	+12.3%	0.003%
5/8/2026	PNC Financial Services Group Inc.	5,630	$0.74M	0.0%	+12.2%	0.006%
5/8/2026	Oslo Pensjonsforsikring AS	1,081	$0.14M	0.0%	N/A	0.001%
5/8/2026	Andra AP fonden	148,191	$19.52M	0.2%	+118.2%	0.147%
5/8/2026	Summit Global Investments	17,083	$2.25M	0.1%	-31.1%	0.017%
5/8/2026	Cassaday & Co Wealth Management LLC	254	$33K	0.0%	N/A	0.000%
5/7/2026	Earned Wealth Advisors LLC	3,093	$0.41M	0.0%	+17.3%	0.003%
5/7/2026	Dimensional Fund Advisors LP	711,762	$93.75M	0.0%	-0.7%	0.708%
5/7/2026	Compound Planning Inc.	1,776	$0.23M	0.0%	-4.4%	0.002%
5/7/2026	AlphaCentric Advisors LLC	9,607	$1.27M	1.3%	+30.1%	0.010%
5/7/2026	KBC Group NV	17,011	$2.24M	0.0%	-47.5%	0.017%
5/7/2026	SEB Asset Management AB	79,577	$10.48M	0.0%	N/A	0.079%
5/7/2026	Swiss National Bank	292,600	$38.55M	0.0%	+7.7%	0.291%
5/7/2026	Mediolanum International Funds Ltd	10,094	$1.30M	0.0%	-80.4%	0.010%
5/6/2026	Aurora Investment Counsel	10,201	$1.34M	0.7%	-5.7%	0.010%
5/6/2026	California Public Employees Retirement System	222,441	$29.30M	0.0%	+13.0%	0.221%
5/6/2026	Kera Capital Partners Inc.	2,068	$0.27M	0.0%	-5.5%	0.002%
5/6/2026	Assetmark Inc.	17,277	$2.28M	0.0%	-10.6%	0.017%
5/6/2026	Gallacher Capital Management LLC	1,758	$0.23M	0.1%	N/A	0.002%
5/6/2026	Financiere des Professionnels Fonds d investissement inc.	10,302	$1.36M	0.1%	-6.3%	0.010%
5/6/2026	Allspring Global Investments Holdings LLC	332,408	$44.06M	0.1%	-2.1%	0.330%
5/6/2026	Aware Super Pty Ltd as trustee of Aware Super	136,786	$18.02M	0.3%	N/A	0.136%
5/5/2026	Bank of New York Mellon Corp	702,492	$92.55M	0.0%	-4.9%	0.698%
5/5/2026	Sanctuary Advisors LLC	7,879	$1.04M	0.0%	-6.8%	0.008%
5/4/2026	AMG National Trust Bank	11,797	$1.55M	0.0%	-4.3%	0.012%
5/4/2026	State of Michigan Retirement System	24,181	$3.19M	0.0%	+2.5%	0.024%
5/4/2026	Principal Financial Group Inc.	238,161	$31.38M	0.0%	+5.2%	0.237%
5/4/2026	Chicago Partners Investment Group LLC	7,389	$0.97M	0.0%	+37.9%	0.007%
5/4/2026	Triglav Investments D.O.O.	9,000	$1.19M	0.1%	-10.0%	0.009%
5/2/2026	Diversify Wealth Management LLC	1,597	$0.21M	0.0%	N/A	0.002%
5/1/2026	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	25,146	$3.31M	0.0%	+0.8%	0.025%
5/1/2026	Citizens Financial Group Inc. RI	3,254	$0.43M	0.0%	N/A	0.003%
5/1/2026	Fifth Third Bancorp	27,393	$3.61M	0.0%	+3,070.5%	0.027%
5/1/2026	Candriam S.C.A.	275,064	$36.24M	0.2%	-6.2%	0.273%
5/1/2026	Sequoia Financial Advisors LLC	4,849	$0.64M	0.0%	-15.6%	0.005%
4/30/2026	Hsbc Holdings PLC	184,222	$24.30M	0.0%	+169.8%	0.183%
4/30/2026	Graetz Wealth LLC	1,868	$0.25M	0.2%	+14.1%	0.002%

Data available starting January 2016

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy in pediatrics and adults; NBI-921352 to treat developmental and epileptic encephalopathy syndrome in pediatrics and adults; NBI-827104 to treat epileptic encephalopathy with continuous spike-and-wave during sleep; NBI-1076986 to treat movement disorders; crinecerfront to treat congenital adrenal hyperplasia in adults and children; EFMODY to treat congenital adrenal hyperplasia and adrenal insufficiency in adults; valbenazine for the adjunctive treatment of schizophrenia; NBI-1065845 for the treatment of inadequate response to treatment in major depressive disorder; luvadaxistat to treat cognitive impairment related to schizophrenia; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; NBI-1117570 for the treatment of symptoms of psychosis and cognition in neurological and neuropsychiatric conditions; and NBI-1117569, NBI-1117567, and NBI-1065890 to treat CNS indications. The company also has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Today's Range

Now: $166.80

$164.56

$185.55

50 Day Range

MA: $167.81

$154.84

$185.50

52 Week Range

Now: $166.80

$122.14

$186.12

Volume

4,584,217 shs

Average Volume

1,329,654 shs

Market Capitalization

$16.77 billion

P/E Ratio

24.46

Dividend Yield

N/A

Beta

0.39

Who are the company insiders with the largest holdings of Neurocrine Biosciences?: Neurocrine Biosciences' top insider shareholders include:
Neurocrine Biosciences Inc (Major Shareholder)
Kevin Charles Gorman (CEO)
Kevin Charles Gorman (Director)
Gary A Lyons (Director)
Gary A Lyons (Director)
Haig P Bozigian (Insider)
Darin Lippoldt (Insider)
Dimitri E Grigoriadis (Insider)
Kyle Gano (CEO)
Timothy P Coughlin (CFO)
Learn More about top insider investors at Neurocrine Biosciences.
Who are the major institutional investors of Neurocrine Biosciences?: Neurocrine Biosciences' top institutional investors include:
Assenagon Asset Management S.A. — 0.22%
Handelsbanken Fonder AB — 0.20%
PKO BP BANKOWY Universal Pension Society JSC — 0.17%
PensionDanmark Pensionsforsikringsaktieselskab — 0.04%
Red Spruce Capital LLC — 0.02%
BDF Gestion — 0.01%
Learn More about top institutional investors of Neurocrine Biosciences stock.
Which institutional investors are selling Neurocrine Biosciences stock?: During the previous quarter, NBIX stock was sold by these institutional investors:
Private Client Services LLC
Red Spruce Capital LLC
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
Kevin Charles Gorman (Director)
Kyle Gano (CEO)
Darin Lippoldt (Insider)
William H Rastetter (Director)
Richard F Pops (Director)
Jude Onyia (Insider)
Julie Cooke (Insider)
Ingrid Delaet (Insider)
Stephen A Sherwin (Director)
David W Boyer (Insider)
Leslie V Norwalk (Director)
George J Morrow (Director)
Learn More investors selling Neurocrine Biosciences stock.
Which institutional investors are buying Neurocrine Biosciences stock?: Within the previous quarter, NBIX stock was bought by institutional investors including:
Assenagon Asset Management S.A.
PKO BP BANKOWY Universal Pension Society JSC
Handelsbanken Fonder AB
BDF Gestion
PensionDanmark Pensionsforsikringsaktieselskab
Avior Wealth Management LLC
City Center Advisors LLC
Generali Investments Management Co LLC